title: Decreased longevity and enhancement of age-dependent lesions in mice lacking the nuclear receptor peroxisome proliferator-activated receptor alpha (PPARalpha).
abstract: The nuclear receptor peroxisome proliferator-activated receptor alpha (PPARalpha) is activated by peroxisome proliferators (PP), a large class of structurally diverse xenobiotic chemicals, hypolipidemic drugs, and endogenous lipids. PPARalpha alters the transcriptional programs of genes whose functions include lipid metabolism, inflammation, cell fate, and stress responses in liver, heart, kidney, and skin. Many of these genes are also under control of PPARalpha in the absence of exogenous peroxisome proliferator exposure. Mice that lack PPARalpha (PPARalpha-null mice) exhibit a number of defects in lipid metabolism and accumulate lipids in the liver. Here, we compared the age-dependent lesions in the liver, kidney, and heart in PPARalpha-null mice with those observed in wild-type SV129 mice, in the absence of exogenous chemical exposure. Groups of mice were sacrificed, at 6, 12, 18, 21, or 24 months of age, or allowed to age until moribund or found dead. PPARalpha-null mice had decreased longevity, due to a variety of causes. Statistically significant differences in the occurrence of a number of lesions between strains was observed. Hepatocellular carcinomas and multiple hepatocellular adenomas occurred in PPARa-null mice but not wild type mice. Various nonneoplastic spontaneous aging lesions occurred at higher incidence, shorter latency, or increased severity in PPARalpha-null mice compared with wild-type mice. In the liver, these included vacuolated hepatocytes and sinusoidal cells and mixed cell inflammation. The kidneys of PPARalpha-null mice exhibited higher incidences and severities of cortical mineralization. Minimal myocardial mineralization occurred at a higher incidence in PPARalpha-null mice. Our results imply that PPARalpha delays the development of some spontaneous lesions associated with aging in the liver, kidney, and heart of SV129 mice.
authors.affiliation: Experimental Pathology Laboratories, Inc., PO Box 12766, Research Triangle Park, North Carolina 27709, USA.
authors.forename: Paul
authors.initials: P
authors.lastname: Howroyd
authors.forename: Cyndi
authors.initials: C
authors.lastname: Swanson
authors.forename: Corrie
authors.initials: C
authors.lastname: Dunn
authors.forename: Russell C
authors.initials: RC
authors.lastname: Cattley
authors.forename: J Christopher
authors.initials: JC
authors.lastname: Corton
mesh_terms: D018248:Adenoma, Liver Cell / Q000235:genetics / Q000473:pathology; D000375:Aging / Q000235:genetics / Q000473:pathology*; D000818:Animals; D002114:Calcinosis; D006528:Carcinoma, Hepatocellular / Q000235:genetics / Q000473:pathology; D020022:Genetic Predisposition to Disease; D007668:Kidney / Q000473:pathology*; D007672:Kidney Cortex / Q000473:pathology; D007674:Kidney Diseases / Q000235:genetics / Q000473:pathology; D008099:Liver / Q000473:pathology*; D008113:Liver Neoplasms / Q000235:genetics / Q000473:pathology; D008136:Longevity / Q000235:genetics; D051379:Mice; D008815:Mice, Inbred Strains; D018345:Mice, Knockout; D009206:Myocardium / Q000473:pathology*; D047493:PPAR alpha / Q000172:deficiency* / Q000235:genetics
chemical_list: D047493:PPAR alpha